James Coyne tells PACE authors: Stop fighting data release

Share on facebook
Share on twitter
Share on email

Professor James Coyne today publicly urged the PACE trial authors and Queen Mary University of London to stop fighting the release of raw data from the study. He used his popular blog in a powerful call to those responsible for withholding the information from the £5 million, taxpayer-funded trial to “let the People’s data go”.
The controversial UK-based PACE trial studied the effect of cognitive behavioural therapy and graded exercise therapy on patients with chronic fatigue syndrome. All of the planned main outcome analyses and the thresholds used to define recovery were abandoned during the trial and replaced with new ones.
Results according to the original analyses were never published and the study authors have rejected requests under the Freedom of Information Act for both the results and for raw data that would allow independent researchers to calculate them.
Following a complaint from someone whom Coyne describes as a “citizen-scientist patient”, the Information Commissioner has now ordered the study authors to release the data or face contempt of court. This, says Coyne, is a “landmark decision” but the authors have been given 28 days to appeal.
Coyne says that “scientists need to watch closely” whether the PACE decision is overturned. He quotes bioethicist and fellow University of Pennsylvania academic Jon Merz, who said, “The litany of excuses – not reasons – offered by the researchers and Queen Mary University is a bald attempt to avoid transparency and accountability, hiding behind legal walls instead of meeting their critics on a level playing field.  They should be willing to provide the data for independent analyses in pursuit of the truth.”
Coyne cites policies of the Medical Research Council who funded the trial, as well as the Wellcome Trust and the Cochrane Collaboration, favouring the open sharing of data as a public good.  But, he notes, enforcement is weak, particularly in the US where requirements for data-sharing “have no teeth” and where the situation “would be worsened by reversal of [the Information Commissioner’s] decision.”
“Investigators just need to live with the possibility that their claims will be proven wrong or exaggerated,” said Coyne. “This is all the more true for claims that have substantial impact on public policy and clinical services, and ultimately, patient welfare.”
Coyne entered the long-running PACE controversy on October 29 with a blog post explaining why the latest PACE publication in Lancet Psychiatry was “uninterpretable” and had used “voodoo statistics”.
His involvement was sparked by a comment by one of the PACE investigators, Professor Michael Sharpe, reported in a much-criticised Daily Telegraph article, that patients “get locked into a pattern and their life constricts around what they can do. If you live within your limits that becomes a self-fulfilling prophesy.” Coyne said on Twitter: “I’ve had it. Sharpe quotes are offensive. Will lay waste to PACE follow up study… in blog post.”
Since then, Coyne has begun work with Professor Keith Laws to write a letter to Lancet Psychiatry about flaws in the trial. Laws is Professor of Cognitive Neuropsychology at the University of Hertfordshire, and is himself the author of two recent blog posts (here and here) criticising PACE.
Coyne will give a public talk in Edinburgh on Monday 16 November about the PACE trial, including these issues of data release. He says, “Events are still unfolding, but it appears that there are major changes going on around how we think and talk about ME/CFS and its sufferers.”
An #MEAction petition calling for the release of data from the trial and the retraction of misleading results has already gained over 9,300 signatures in two weeks, with a target of 10,000.

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on google
Google+
Share on email
Email

2 thoughts on “James Coyne tells PACE authors: Stop fighting data release”

  1. Thank you for such a clear summary. Is there any reason at all why the data cannot be released? It isn’t as if we could look at the line of data 60, 65, 28, 25, 10, 10, yes, yes, 4, 3, 321, 332, GET and announce to the world, “Yes, that’s Annie Gsampel! I’d recognise her anywhere!”
    Well there is a reason: perhaps the data is much less of a gold-standard proof that NICE and others in the medical hierarchy make out it to be.
    We need to start a campaign: Free Annie Gsample!

Leave a Comment

Your email address will not be published. Required fields are marked *

Latest News

Sign petition To Fix ME/CFS tracking In US!

In August, we shared with you that we and six other ME/CFS organizations had submitted a proposal to the National Center of Health Statistics (NCHS) to fix the coding of ME/CFS in the US International Classification of Diseases (ICD-10-CM). Today, we are writing with an update on that proposal and asking that you sign the

Read More »

NICE announces roundtable event to ensure implementation of ME/CFS guideline

NICE announced today that it will hold a roundtable in September as the next step in the publication of the ME/CFS guideline. The roundtable will include representatives from patient organisations and charities, relevant professional societies, NHS England and NHS Improvement, NICE and the guideline committee. It aims to, “better understand the issues raised and determine

Read More »

#MEAction & 6 ME Orgs Call for CDC to Change How it Tracks ME/CFS

Together with six other organizations, we have submitted a proposal to the National Center for Health Statistics (NCHS) to add myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) to the neurological chapter of the International Classification of Diseases (ICD-10-CM).  Today, ME/CFS does not exist in the US ICD-10-CM. Instead,  most US doctors assign the code for chronic fatigue

Read More »

Help keep our work going

We rely on donations from people like you to keep fighting for equality for people with ME.

Donate

Get actions alerts and news direct to your inbox

You can choose what you want to be kept up to date on.

Subscribe
Scroll to Top